View in EDS

First-in-Human Study of CEB-01: Novel Loco-Regional SN-38-Releasing Membrane to Prevent Local Recurrence in Retroperitoneal Sarcomas.

Saved in:
Bibliographic Details
Title: First-in-Human Study of CEB-01: Novel Loco-Regional SN-38-Releasing Membrane to Prevent Local Recurrence in Retroperitoneal Sarcomas.
Authors: Gonzalez JA; Department of Surgery, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain., Sebio A; Medical Oncology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain. asebio@santpau.cat., Martin-Broto J; Medical Oncology Department, Hospital Universitario Fundación Jiménez Díaz and Villalba General Hospital, Madrid, Spain., Hindi N; Medical Oncology Department, Hospital Universitario Fundación Jiménez Díaz and Villalba General Hospital, Madrid, Spain., Villarejo-Campos P; Department of Surgery, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain., Jiménez M; Department of Surgery, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain., Díaz-Beveridge R; Medical Oncology Department, Hospital Universitario y Politécnico La Fe, Valencia, Spain., Orbis Castellanos JF; Department of Surgery, Hospital Universitario y Politécnico La Fe, Valencia, Spain., López Andújar R; Department of Surgery, Hospital Universitario y Politécnico La Fe, Valencia, Spain., Álvarez Álvarez R; Medical Oncology Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain., Asencio JM; Department of Surgery, Hospital General Universitario Gregorio Marañón, Madrid, Spain., Serrano C; Medical Oncology Department, Hospital Universitario Vall d'Hebron, Vall d'Hebron Institute of Oncology, Barcelona, Spain., Rodríguez Conde N; Servicio de Cirugía General y Digestiva, Hospital Universitario Vall d'Hebron, Barcelona, Spain., Castro Boix S; Servicio de Cirugía General y Digestiva, Hospital Universitario Vall d'Hebron, Barcelona, Spain., Krauel L; Pediatric Surgery Department, SJD Barcelona Children's Hospital, Universitat de Barcelona, Barcelona, Spain., Colom Codina H; Pharmaceutical Technology & Physical-Chemistry Department, School of Pharmacy, University of Barcelona, Barcelona, Spain., Tornero García JA; Universitat Politècnica de Catalunya (UPC), Barcelona, Spain.; Cebiotex S.L., Barcelona, Spain., Lopera de Llanos E; Cebiotex S.L., Barcelona, Spain., Huguet Ninou A; Cebiotex S.L., Barcelona, Spain., Pérez Campos A; Cebiotex S.L., Barcelona, Spain., Gruber AK; Cebiotex S.L., Barcelona, Spain., López Pousa A; Medical Oncology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
Source: Annals of surgical oncology [Ann Surg Oncol] 2026 Aug; Vol. 33 (8), pp. 7677-7687. Date of Electronic Publication: 2026 Apr 17.
Publication Type: Clinical Trial, Phase I; Journal Article; Multicenter Study; Randomized Controlled Trial
Journal Info: Publisher: Springer Country of Publication: United States NLM ID: 9420840 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1534-4681 (Electronic) Linking ISSN: 10689265 NLM ISO Abbreviation: Ann Surg Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1534-4681
DOI:10.1245/s10434-026-19487-3